The following table provides pro forma results of operations for the fiscal year ended December 30, 2012 and January 1, 2012, as if Synthes, Inc. had been acquired as of January 3, 2011. The pro forma results include the effect of divestitures and certain purchase accounting adjustments such as the estimated changes in depreciation and amortization expense on the acquired tangible and intangible assets. However, pro forma results do not include any anticipated cost savings or other effects of the integration of Synthes, Inc. Accordingly, such amounts are not necessarily indicative of the results if the acquisition had occurred on the dates indicated or which may occur in the future.
|
| | | | | |
| Unaudited Pro forma consolidated results |
(Dollars in Millions Except Per Share Amounts) | 2012 | 2011 |
| | |
Net Sales | $ | 68,894 |
| 68,741 |
|
Net Earnings attributable to Johnson & Johnson | $ | 11,564 |
| 9,427 |
|
Diluted Net Earnings per share attributable to Johnson & Johnson | $ | 4.11 |
| 3.40 |
|
